Skip to content
2000
Volume 8, Issue 3
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Levels of melatonin in mammalian circulation are well documented; however, its levels in tissues and other body fluids are yet only poorly established. It is obvious that melatonin concentrations in cerebrospinal fluid (CSF) of mammals including humans are substantially higher than those in the peripheral circulation. Evidence indicates that melatonin produced in pineal gland is directly released into third ventricle via the pineal recess. In addition, brain tissue is equipped with the synthetic machinery for melatonin production and the astrocytes and glial cells have been proven to produce melatonin. These two sources of melatonin may be responsible for its high levels in CNS. The physiological significance of the high levels of melatonin in CNS presumably is to protect neurons and glia from oxidative stress. Melatonin as a potent antioxidant has been reported to be a neuroprotector in animals and in clinical studies. It seems that long term melatonin administration which elevates CSF melatonin concentrations will retard the progression of neurodegenerative disorders, for example, Alzheimer disease.

Loading

Article metrics loading...

/content/journals/cn/10.2174/157015910792246182
2010-09-01
2024-11-16
Loading full text...

Full text loading...

/content/journals/cn/10.2174/157015910792246182
Loading

  • Article Type:
    Research Article
Keyword(s): CNS; CSF; Melatonin; neurodegenerative disease; oxidative stress; pineal gland
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test